Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)

Clinical trial NCT00162929 · COMPLETED

Trial details

NCT number: NCT00162929
Sponsor: Ontario Clinical Oncology Group (OCOG)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2005-01-01
Primary completion: 2009-07-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.